Old Web
English
Sign In
Acemap
>
Paper
>
Mo1221 Comparative Assessments of PF-06438179, a Potential Biosimilar, and Infliximab in a Phase 1 Pharmacokinetic Study
Mo1221 Comparative Assessments of PF-06438179, a Potential Biosimilar, and Infliximab in a Phase 1 Pharmacokinetic Study
2015
D. Yin
Chandrasekhar Udata
Steven Y. Hua
S. Salts
Xu Meng
Theodore R. Johnson
Mazin Derzi
Hugh D. Conlon
Carol Kirchhoff
M.I. Rehman
Keywords:
Biosimilar
Infliximab
Pharmacology
Pharmacokinetics
Medicine
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]